Cargando…

Systemic Immune Dysregulation in Early Breast Cancer Is Associated With Decreased Plasma Levels of Both Soluble Co-Inhibitory and Co-Stimulatory Immune Checkpoint Molecules

Breast cancer cells exploit the up-regulation or down-regulation of immune checkpoint proteins to evade anti-tumor immune responses. To explore the possible involvement of this mechanism in promoting systemic immunosuppression, the pre-treatment levels of soluble co-inhibitory and co-stimulatory imm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rapoport, Bernardo L., Steel, Helen C., Hlatshwayo, Nomsa, Theron, Annette J., Meyer, Pieter W. A., Nayler, Simon, Benn, Carol-Ann, Smit, Teresa, Kwofie, Luyanda L. I., Heyman, Liezl, Anderson, Ronald
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168983/ https://www.ncbi.nlm.nih.gov/pubmed/35677046 http://dx.doi.org/10.3389/fimmu.2022.823842

Ejemplares similares

Dysregulation of systemic soluble immune checkpoints in early breast cancer is attenuated following administration of neoadjuvant chemotherapy and is associated with recovery of CD27, CD28, CD40, CD80, ICOS and GITR and substantially increased levels of PD-L1, LAG-3 and TIM-3
por: Rapoport, Bernardo L., et al.
Publicado: (2023)

Systemic levels of the soluble co-inhibitory immune checkpoints, CTLA-4, LAG-3, PD-1/PD-L1 and TIM-3 are markedly increased in basal cell carcinoma
por: Malinga, Nonkululeko Z., et al.
Publicado: (2022)

High Mobility Group Box 1 in Human Cancer
por: Rapoport, Bernardo L., et al.
Publicado: (2020)

Tumor-Infiltrating Lymphocytes (TILs) in Early Breast Cancer Patients: High CD3(+), CD8(+), and Immunoscore Are Associated with a Pathological Complete Response
por: Rapoport, Bernardo Leon, et al.
Publicado: (2022)

Immune Dysregulation in Cancer Patients Undergoing Immune Checkpoint Inhibitor Treatment and Potential Predictive Strategies for Future Clinical Practice
por: Anderson, Ronald, et al.
Publicado: (2018)

Elevated Levels of Soluble CTLA-4, PD-1, PD-L1, LAG-3 and TIM-3 and Systemic Inflammatory Stress as Potential Contributors to Immune Suppression and Generalized Tumorigenesis in a Cohort of South African Xeroderma Pigmentosum Patients
por: Kgokolo, Mahlatse C. M., et al.
Publicado: (2022)

What do we know about co-stimulatory and co-inhibitory immune checkpoint signals in ankylosing spondylitis?
por: Schütz, Christian, et al.
Publicado: (2023)

Effects of Tobacco Usage and Antiretroviral Therapy on Biomarkers of Systemic Immune Activation in HIV-Infected Participants
por: Steel, Helen C., et al.
Publicado: (2018)

Immunopathogenesis of Immune Checkpoint Inhibitor-Related Adverse Events: Roles of the Intestinal Microbiome and Th17 Cells
por: Anderson, Ronald, et al.
Publicado: (2019)

Co-stimulatory and immune checkpoint molecules are important in the tumor microenvironment of Hodgkin-like adult T-cell leukemia/lymphoma
por: Takeuchi, Mai, et al.
Publicado: (2023)

Co-stimulatory and co-inhibitory immune markers in solid tumors with MET alterations
por: Reckamp, Karen L, et al.
Publicado: (2020)

Soluble Immune Checkpoints Are Dysregulated in COVID-19 and Heavy Alcohol Users With HIV Infection
por: Li, Wei, et al.
Publicado: (2022)

Evaluation of three different laboratory methods to detect preformed human leukocyte antigen antibodies in a South African kidney transplant population
por: Kwofie, Luyanda, et al.
Publicado: (2021)

Co-Stimulatory Molecules during Immune Control of Epstein Barr Virus Infection
por: Münz, Christian
Publicado: (2021)

Editorial: Management of Immune-Related Adverse Events for Patients Undergoing Treatment With Checkpoint Inhibitors
por: Rapoport, Bernardo Leon
Publicado: (2019)

Inorganic nanosheets facilitate humoral immunity against medical implant infections by modulating immune co-stimulatory pathways
por: Yang, Chuang, et al.
Publicado: (2022)

Modulating expression of inhibitory and stimulatory immune ‘checkpoints’ using nanoparticulate-assisted nucleic acid delivery
por: Walters, Adam A, et al.
Publicado: (2021)

Role of the Neutrophil in the Pathogenesis of Advanced Cancer and Impaired Responsiveness to Therapy†
por: Rapoport, Bernardo L., et al.
Publicado: (2020)

T-cell co-stimulatory pathways in autoimmunity
por: Goronzy, Jörg J, et al.
Publicado: (2008)

Immune Checkpoint Axes Are Dysregulated in Patients With Alcoholic Hepatitis
por: Li, Wei, et al.
Publicado: (2020)

Recent advances, patient selection & challenges in managing cancer patients undergoing treatment with immune checkpoint inhibitors
por: Rapoport, Bernardo Leon, et al.
Publicado: (2022)

Prognostic impacts of soluble immune checkpoint regulators and cytokines in patients with SARS-CoV-2 infection
por: Lee, Nuri, et al.
Publicado: (2022)

Stimulatory Effect of β-glucans on Immune Cells
por: Kim, Hyung Sook, et al.
Publicado: (2011)

T cell co-stimulatory and co-inhibitory pathways in atopic dermatitis
por: Zheng, Chunjiao, et al.
Publicado: (2023)

Targeting Co-Stimulatory Pathways in Gene Therapy
por: Huang, Xiaopei, et al.
Publicado: (2011)

The Role of Co-Stimulatory Molecules in Chagas Disease
por: Pinto, Bruna F., et al.
Publicado: (2018)

Co-stimulatory agonists: An insight into the immunotherapy of cancer
por: Pourakbari, Ramin, et al.
Publicado: (2021)

Co-Stimulatory Receptor Signaling in CAR-T Cells
por: Honikel, Mackenzie M., et al.
Publicado: (2022)

Editorial: Soluble immune checkpoints: Novel physiological immunomodulators
por: Riva, Antonio
Publicado: (2023)

A South African Breast Implant-Associated Anaplastic Large Cell Lymphoma: Clinical Presentation and Six-Year Follow-Up
por: Grubnik, Alexandra, et al.
Publicado: (2022)

Aberrant Expressions of Co-stimulatory and Co-inhibitory Molecules in Autoimmune Diseases
por: He, Weiwei, et al.
Publicado: (2019)

Immune Dysregulation in Acute SARS-CoV-2 Infection
por: Grimm, Lauren, et al.
Publicado: (2023)

Soluble immune checkpoints in cancer: production, function and biological significance
por: Gu, Daqian, et al.
Publicado: (2018)

Soluble immune checkpoints are elevated in patients with primary biliary cholangitis
por: Gao, Xiuzhu, et al.
Publicado: (2023)

Dichotomous roles of co-stimulatory molecules in diabetes mellitus
por: Zhong, Ji-Xin, et al.
Publicado: (2017)

Co-Stimulatory Receptors in Cancers and Their Implications for Cancer Immunotherapy
por: Jeong, Seongju, et al.
Publicado: (2020)

Assessment of soluble immune mediators as potential biomarkers during immune checkpoint inhibitor therapy
por: Matsuo, Norikazu, et al.
Publicado: (2019)

Unravelling soluble immune checkpoints in chronic lymphocytic leukemia: Physiological immunomodulators or immune dysfunction
por: Landeira-Viñuela, Alicia, et al.
Publicado: (2022)

Aberrant Glycosylation Augments the Immuno-Stimulatory Activities of Soluble Calreticulin
por: Gong, Fang-Yuan, et al.
Publicado: (2018)

Tailored design of NKT-stimulatory glycolipids for polarization of immune responses
por: Hung, Jung-Tung, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ljefiprseg93d5b320ok4nik73